Navigation Links
Actinium Pharmaceuticals Announces The Addition of The Fred Hutchinson Cancer Research Center To Actinium's Multicenter Clinical Trial For Patients With Acute Myeloid Leukemia
Date:8/1/2012

NEWARK, N.J., Aug. 1, 2012 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (API), a biopharmaceutical company that develops innovative targeted payload immunotherapeutics, announced that Fred Hutchinson Cancer Research Center has become a clinical site for the Company's ongoing Phase I/II trial in newly diagnosed patients with acute myeloid leukemia (AML).  The trial is designed to establish safety and efficacy of API's drug Actimab-A in AML patients over the age of 60.  Actimab-A treatment consists of the isotope Actinium 225 attached to the anti-CD33 monoclonal antibody lintuzumab (HuM195). 

"We are delighted that The Fred Hutchinson Cancer Research Center joined our trial," said Dr. Dragan Cicic, CEO of Actinium Pharmaceuticals.  "The Fred Hutchinson Cancer Research Center's participation adds another layer to the relationship between our company and this pre-eminent institution and from which we have recently in-licensed BC8, another radiolabeled antibody for treatment of hematologic malignancies, which allowed us to strengthen our product portfolio with a late stage product that has already been in more than 250 patients and continues its development in a number of active trials with impressive results."

Phase I/II multi-center Actimab study will build on the previous phase 1/2 Bismab-A study with a less potent bismuth-213 (Bi-213) isotope and an earlier Actimab-A phase 1 study (where only one dose was administered).  The Phase 2 portion of the Bismab-A study demonstrated efficacy of API's alpha particle platform by producing a number of complete responses in difficult-to-treat relapsed, secondary and poor cytogenetics patients with no standard of care options available. The goal of the current study is to confirm efficacy and safety of Actimab-A, produced by an improved method of manufacture, and to study the effect of multiple doses of treatment.  The population
'/>"/>

SOURCE Actinium Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Actinium Pharmaceuticals Inc. Pays Regulatory Milestone to Abbott Biotherapeutics Corp.
2. Synergy Pharmaceuticals to Present Scientific Posters at the Upcoming Gastroenterology Society Meetings in the U.S. and Europe
3. Inovio Pharmaceuticals Inc. to Webcast, Live, at RetailInvestorConferences.com on August 2nd
4. Nouveau Life Pharmaceuticals (NOUV) Releases Krill Oil to Support Healthy Cholesterol Levels and Reduce Inflammation
5. Kinex Pharmaceuticals Receives Substantial Strategic Investment
6. Auxilium Pharmaceuticals, Inc. Announces Second Quarter 2012 Financial Results
7. Lexicon Pharmaceuticals Reports On Clinical Program Status And 2012 Second Quarter Results
8. Consumers Choosing Organic Alternatives to Traditional Pharmaceuticals
9. Catherine Sohn Elected To Jazz Pharmaceuticals Board Of Directors
10. Stephen G. Austin, CPA Joins Imprimis Pharmaceuticals Board Of Directors
11. Jason Pharmaceuticals, Inc. Reaches Proposed Consent Agreement with FTC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... April 21, 2015   Rock Creek Pharmaceuticals, Inc., ... focused on the treatment of chronic inflammatory disorders, announced ... to the Company,s Board of Directors with the recent ... a new director. Michael Mullan ... Pharmaceuticals, said, "Dr. Samuel,s experience in advancing biotechnology products ...
(Date:4/21/2015)... , April 21, 2015  Direct contracting continues ... as aptitude marks its second anniversary.  With over ... platform, single hospital entities, large integrated delivery systems ... that cover medical surgical items, clinical preference products ... cost effective - complementary contracting strategy, aptitude seeks ...
(Date:4/21/2015)... , April 21, 2015  Game-changing ... the latest being the European Commission,s ruling on ... global leader and champion of pharmaceutical supply ... of meeting these mandates and offers several tools ... many countries. From an upcoming webinar in May ...
Breaking Medicine Technology:Rock Creek Pharmaceuticals Appoints New Director and Provides Notice of Settlement of Derivative Litigation 2Rock Creek Pharmaceuticals Appoints New Director and Provides Notice of Settlement of Derivative Litigation 3Rock Creek Pharmaceuticals Appoints New Director and Provides Notice of Settlement of Derivative Litigation 4Rock Creek Pharmaceuticals Appoints New Director and Provides Notice of Settlement of Derivative Litigation 5Rock Creek Pharmaceuticals Appoints New Director and Provides Notice of Settlement of Derivative Litigation 6Rock Creek Pharmaceuticals Appoints New Director and Provides Notice of Settlement of Derivative Litigation 7Healthcare's first direct contracting market celebrates second anniversary 2Frequentz Gives the Global Pharmaceutical Supply Chain a Shoulder to Lean On as They Face Expanding Serialization Requirements 2Frequentz Gives the Global Pharmaceutical Supply Chain a Shoulder to Lean On as They Face Expanding Serialization Requirements 3
(Date:4/21/2015)... “ ZeroWire ” was featured on NewsWatch as ... look at the latest and coolest technology products and ... for NewsWatch and a technology expert, conducted the review ... system and lifestyle management hub. , According to the ... burglaries in 2010. It goes without saying that home ...
(Date:4/21/2015)... Dallas, Texas (PRWEB) April 21, 2015 ... Review, H1 2015” provides comparative analysis on ... strengthens R&D pipelines by identifying new targets ... products. Complete report with TOC is available ... report also reviews key players involved in ...
(Date:4/21/2015)... NJ (PRWEB) April 21, 2015 ... across platforms and devices, today announced a new enhancement ... of the new Microsoft Office 365 Management Activity API. ... customers to fully audit and take action on all ... , “The new Office 365 Management Activity API provides ...
(Date:4/21/2015)... York, NY (PRWEB) April 21, 2015 ... of advanced delivery technologies and development solutions for ... the launch of ADVASEPT™ Lock, a stopper-less, glass- ... delivery of injectable medications. Easily opened, ADVASEPT Lock ... convenient and functional container closure with the security ...
(Date:4/21/2015)... 2015 The report “Dermatitis ... analysis on the therapeutic development for Dermatitis. ... identifying new targets and MOAs to produce ... TOC is available @ http://www.rnrmarketresearch.com/dermatitis-pipeline-review-h1-2015-market-report.html ... players involved in the therapeutic development for ...
Breaking Medicine News(10 mins):Health News:A Leader in Home Security was Featured on NewsWatch Television 2Health News:Sinusitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 2Health News:Sinusitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 3Health News:AvePoint Integrates Microsoft Office 365 Management Activity API into DocAve Policy Enforcer for Proactive SharePoint Monitoring 2Health News:AvePoint Integrates Microsoft Office 365 Management Activity API into DocAve Policy Enforcer for Proactive SharePoint Monitoring 3Health News:Catalent Announces the Expansion of its Advanced, Aseptic, Glass-Free Injectable Platform with New ADVASEPT™ Lock Delivery Technology 2Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 2Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 3Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 4
... Smoking has been linked to a number of ... disorders, among others. Early smoking is shown to ... disorders (e.g., panic disorder, generalized anxiety disorder), and ... anxiety) increases the risk for later development of ...
... now become common place owing to the wide scale ... over again, scientists have been working on ways to ... results of a recent research have recently confirmed that ... diseases. ,The leeches have added to the ...
... A new study says that botulinum toxin can be useful ... trigeminal neuralgia. Botulinum or botox as it is popularly known ... and eye spasms. ,Researchers in Brazil and the United ... have detailed their findings in a study published in the ...
... Kollywood stars like Kamal Hassan, Chiranjeevi, Nagarjuna, Venkatesh, Vikram, ... to spread the awareness on AIDS. ,The show ... the Melinda and Bill Gates Foundation was an evening of ... anything in partnership with others. I am very proud of ...
... is likely to invoke the compulsory licensing (CL) provision ... //firms to produce and stockpile Swiss drug maker Roche’s ... against the most dreaded avian flu virus. , ... receipt of an application from the industry. Furthermore, the ...
... Abdominal wall hernias are one of the most common ... repairs// performed annually. Although ventral hernia repair (VHR) is ... problem. Wound infection has been identified as a consistent ... recent study, which appears in the November issue of ...
Cached Medicine News:Health News:Smokers Are Prone To Number Of Psychiatric Disorders 2Health News:Leeches Provide Clues Regarding The Prevention Of Heart Disease 2Health News:Predictors Of Wound Infection In Ventral Hernia Repair 2
Inquire...
The autoclavable, aluminum needle box is designed to store loaded needles and help protect personnel from exposure. Each shield consists of an aluminum box with faceplate to match the grid pattern th...
... Brachytherapy loaders allow for efficient, easy ... Connectors to your customized plans at ... Bard loaders is the flexibility to ... in the QuickLoad™ Loader allows for ...
... designed to help you achieve one important ... procedure. All needles are engineered for exceptional ... for smooth entry and exit. A broad ... an ideal match with procedural needs and ...
Medicine Products: